Of
Angelica Slavik, Berlin
When purchasing medicines, the price should no longer be the most important factor in the future. This emerges from a key issues paper for a legislative project by Federal Health Minister Karl Lauterbach (SPD), which is available to the SZ. Lauterbach is thus reacting to the supply bottlenecks for many medicines. Around 300 medicines are currently not available in Germany, including numerous medicines for children.